Literature DB >> 3780130

Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension.

J I Drayer, W D Hall, V E Smith, M A Weber, G L Wollam, W B White.   

Abstract

Reductions in left ventricular (LV) mass have been reported after antihypertensive therapy with certain sympatholytic agents and converting enzyme inhibitors, but little or no improvement has been noted after vasodilator therapy. In this study we evaluated the effect of the calcium channel blocker nitrendipine on echocardiographic LV mass. During a 12-month period, nitrendipine was used as monotherapy in 30 patients and in combination with propranolol or a diuretic in an additional 28 patients. Nitrendipine monotherapy lowered supine blood pressure from 148/97 to 136/83 mm Hg, but LV mass did not change significantly. Supine blood pressure decreased from 155/103 to 134/86 mm Hg in patients receiving combination therapy but, again, changes in LV mass were not significant. These data suggest that nitrendipine is effective in lowering blood pressure, but this is not associated with a significant decrease in LV mass in patients with mild hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780130     DOI: 10.1038/clpt.1986.244

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  Left ventricular mass changes with nicardipine therapy in essential hypertension.

Authors:  P Gosse; P Lacroix; R Roudaut; M Dallocchio
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

2.  Evaluation of the effectiveness of isradipine SRO in the treatment of hypertensive patients with left ventricular hypertrophy.

Authors:  M G Modena; G Masciocco; R Rossi; P Baraldi; G Mattioli
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 3.  Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?

Authors:  F H Messerli; F Soria
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 4.  Left ventricular hypertrophy and antihypertensive therapy.

Authors:  F H Messerli; S Oren; E Grossman
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.